Jose L Pablos Selected Research

Thromboxane B2

1/2018

Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose L Pablos Research Topics

Disease

5	Rheumatoid Arthritis 01/2019 - 10/2005
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 12/2020
1	Arthritis (Polyarthritis) 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2019
1	Lupus Nephritis 01/2018
1	Nephritis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Proteinuria 01/2018
1	Infections 12/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2009
1	Neoplasms (Cancer) 09/2008
1	Autoimmune Diseases (Autoimmune Disease) 09/2008
1	Disease Susceptibility (Diathesis) 10/2005

Drug/Important Bio-Agent (IBA)

2	ABP 501IBA 01/2019 - 10/2017
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 12/2020
1	Lamin Type A (Lamin A)IBA 12/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	Thromboxane B2IBA 01/2018
1	Antiphospholipid AntibodiesIBA 01/2018
1	AlbuminsIBA 01/2018
1	AntibodiesIBA 01/2018
1	Cardiolipins (Cardiolipin)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	CreatinineIBA 01/2018
1	Biosimilar PharmaceuticalsIBA 10/2017
1	Adalimumab (Humira)FDA Link 10/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2017
1	Virus ReceptorsIBA 12/2014
1	Intergenic DNA (Junk DNA)IBA 01/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	enhanced green fluorescent proteinIBA 10/2006
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2005

Therapy/Procedure

1	Immunotherapy 09/2008